Tumor suppressor miR-139-5p targets Tspan3 and regulates the progression of acute myeloid leukemia through the PI3K/Akt pathway

MicroRNA-192 regulates cell proliferation and cell cycle transition in acute myeloid leukemia via interaction with CCNT2

(2017) Shun Ke et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

MicroRNA-139-5p regulates proliferation of hematopoietic progenitors and is repressed during BCR-ABL-mediated leukemogenesis

(2016) J. Choi et al.   BLOOD

La voie de signalisation PI3K-AKT-mTOR : description, développement thérapeutique, résistances, marqueurs prédictifs/pronostiques et applications thérapeutiques en cancérologie

(2016) Thibault Brotelle et al.   BULLETIN DU CANCER

Dual tumor-suppressorsmiR-139-5pandmiR-139-3ptargetingmatrix metalloprotease 11in bladder cancer

(2016) Masaya Yonemori et al.   CANCER SCIENCE

MiR-139-5p is Increased in the Peripheral Blood of Patients with Prostate Cancer

(2016) Cheng Pang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1

(2016) Heyong Liu et al.   PATHOLOGY RESEARCH AND PRACTICE

MiR-139-5p is a potent tumor suppressor in adult acute myeloid leukemia

(2016) K Krowiorz et al.   Blood Cancer Journal

Tetraspanin CD81 is an adverse prognostic marker in acute myeloid leukemia

(2016) Thomas Boyer et al.   Oncotarget

MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel

(2015) He-da Zhang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

miR-139-5p inhibits epithelial–mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2

(2015) Gongcai Qiu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Tetraspanin 3 Is Required for the Development and Propagation of Acute Myelogenous Leukemia

(2015) Hyog Young Kwon et al.   Cell Stem Cell

The loss of MiR-139-5p promotes colitis-associated tumorigenesis by mediating PI3K/AKT/Wnt signaling

(2015) Rurong Mao et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Elucidation of monocyte/macrophage dynamics and function by intravital imaging

(2015) Rejane Rua et al.   JOURNAL OF LEUKOCYTE BIOLOGY

miR-139 and miR-200c regulate pancreatic cancer endothelial cell migration and angiogenesis

(2015) LEI LI et al.   ONCOLOGY REPORTS

MiR-139-5p: promising biomarker for cancer

(2015) He-da Zhang et al.   TUMOR BIOLOGY

Tetraspanins as therapeutic targets in hematological malignancy: a concise review

(2015) Kyle A. Beckwith et al.   Frontiers in Physiology

Acute Myeloid Leukemia in Adolescents and Young Adults: Challenging Aspects

(2014) Yishai Ofran et al.   ACTA HAEMATOLOGICA

Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients

(2013) O Chabre et al.   ENDOCRINE-RELATED CANCER

Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies

(2012) Kiyotaka Kawauchi et al.   Anti-Cancer Agents in Medicinal Chemistry

Expression of microRNAs in basal cell carcinoma

(2012) M. Sand et al.   BRITISH JOURNAL OF DERMATOLOGY

An overview of the mTOR pathway as a target in cancer therapy

(2012) Ryan D Gentzler et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Aberrant microRNA expression and its implications in the pathogenesis of leukemias

(2012) Sadegh Babashah et al.   CELLULAR ONCOLOGY

Epigenetic regulation of miRNA genes in acute leukemia

(2011) X Agirre et al.   LEUKEMIA

Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia

(2009) Alberto M Martelli et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS